Watson, A. L., Anderson, L. K., Greeley, A. D., Keng, V. W., Rahrmann, E. P., Halfond, A. L., . . . Largaespada, D. A. (2014). Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. Impact Journals LLC.
Citação norma ChicagoWatson, Adrienne L., et al. Co-targeting the MAPK and PI3K/AKT/mTOR Pathways in Two Genetically Engineered Mouse Models of Schwann Cell Tumors Reduces Tumor Grade and Multiplicity. Impact Journals LLC, 2014.
ציטוט MLAWatson, Adrienne L., et al. Co-targeting the MAPK and PI3K/AKT/mTOR Pathways in Two Genetically Engineered Mouse Models of Schwann Cell Tumors Reduces Tumor Grade and Multiplicity. Impact Journals LLC, 2014.